Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indications for lipid-lowering drugs.

J Davignon1

  • 1Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Quebec, Canada.

European Journal of Clinical Pharmacology
|January 1, 1991
PubMed
Summary

Lowering plasma cholesterol significantly reduces coronary artery disease (CAD) risk, a finding supported by extensive research. However, varying international guidelines and complex treatment algorithms complicate patient care and lipid management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A PCSK9 variant and familial combined hyperlipidaemia.

Journal of medical genetics·2008
Same author

Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools.

Journal of internal medicine·2007
Same author

Cardioprotective and other emerging effects of statins.

International journal of clinical practice. Supplement·2005
Same author

Advances in lipid-lowering therapy in atherosclerosis.

Advances in experimental medicine and biology·2002
Same author

Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects.

The American journal of clinical nutrition·2001
Same author

Interaction of lecithin:cholesterol acyltransferase (LCAT).alpha 2-macroglobulin complex with low density lipoprotein receptor-related protein (LRP). Evidence for an alpha 2-macroglobulin/LRP receptor-mediated system participating in LCAT clearance.

The Journal of biological chemistry·2001

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Public Health

Background:

  • Plasma cholesterol levels show a strong exponential correlation with coronary artery disease (CAD) risk.
  • Clinical trials confirm the significant benefits of lowering plasma cholesterol.
  • International consensus exists on the necessity of reducing lipid levels, particularly LDL-cholesterol, to manage atherosclerosis.

Purpose of the Study:

  • To address the confusion arising from differing international guidelines on CAD risk assessment and lipid-lowering therapy targets.
  • To highlight the shift in focus from treating lipid transport disorders to managing specific lipid level targets.
  • To discuss the complexities and potential pitfalls of current lipid management algorithms.

Main Methods:

  • Review of prospective studies and major clinical trials on cholesterol and CAD.
  • Analysis of international guidelines and treatment algorithms for lipid management.
  • Discussion of the challenges in plasma lipid measurement variability.

Main Results:

  • Established link between elevated plasma cholesterol and increased CAD risk.
  • Proven efficacy of lipid-lowering therapies in delaying, slowing, and regressing atherosclerotic lesions.
  • Emergence of confusion due to country-specific target values and risk assessment criteria.
  • Shift in treatment focus towards specific lipid concentrations rather than underlying disorders.
  • Increased complexity of treatment algorithms leading to potential physician confusion.

Conclusions:

  • Despite clear evidence on cholesterol's role in CAD, inconsistencies in guidelines and complex algorithms hinder effective patient management.
  • There is a need for clearer, more unified strategies in lipid management to ensure optimal patient care.
  • Addressing variability in lipid measurements is crucial for accurate risk assessment and treatment efficacy.

Related Experiment Videos